Zhiwei Chang, Rui-Rui Wang, Xiao-Lei Liu, Dan-Dan Yu, Hui-Qiong Han, Jian He, Yanru Qin. "Anlotinib combined with penpulimab and nab-paclitaxel as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.367